https://www.biospace.com/cue-biopharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-updated-business-highlights
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...
fourth quarterfull yearcuebiopharmareports
https://www.businesstimes.com.sg/companies-markets/ix-biopharma-taps-growing-trend-telemedicine-supply-medication
PHARMACEUTICAL maker iX Biopharma has commenced the supply of the drugs Wafesil and Silcapvia to patients who have consulted their doctors through telemedicine...
ixbiopharmatapsgrowingtrend
https://www.biospace.com/cue-biopharma-to-host-business-update
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and...
business updatecuebiopharmahostcall
https://www.zeebiz.com/agencies/ge-chief-culp-sells-biopharma-business-for-214-billion-87561
Business News: Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the...
biopharma businessgechiefculpsells